Efthimios Koutris

Title: Efthimios Koutris: Innovator in Ophthalmic Pharmaceutical Solutions

Introduction

Efthimios Koutris is a notable inventor based in Greece, recognized for his contributions to the field of ophthalmic pharmaceuticals. His work primarily focuses on developing innovative formulations aimed at treating ocular conditions such as glaucoma and ocular hypertension. Despite having no patents to his name, his research and inventions have the potential to significantly impact the pharmaceutical industry.

Latest Patents

Koutris has been involved in the development of several noteworthy inventions. One of his latest patents is titled "Ophthalmic Pharmaceutical Composition Containing A Carbonic Anhydrase Inhibitor And Method For The Preparation Thereof." This invention relates to a stable pharmaceutical formulation for topical administration that contains a therapeutically effective quantity of Brinzolamide or ophthalmologically acceptable salts thereof, along with an effective quantity of a surfactant such as poloxamer. This formulation is intended for the treatment of ocular hypertension and glaucoma.

Another significant patent is "Pharmaceutical Composition Containing Phosphate Binding Polymer." This invention describes a fast-dissolving tablet that comprises a therapeutically effective amount of a phosphate binding polymer, such as sevelamer or its pharmaceutically acceptable salts or derivatives. The tablet is designed to exhibit limited swelling in the oral cavity, have a pleasant taste and mouth feel, and possess high phosphate binding capacity with fast binding kinetics, requiring limited water intake.

Career Highlights

Efthimios Koutris is currently associated with Expermed S.A., where he continues to innovate in the field of pharmaceuticals. His work is characterized by a commitment to developing effective treatments that address critical health issues.

Collaborations

Koutris collaborates with several professionals in his field, including Evangelos Karavas and Ioanna Koutri. These collaborations enhance the research and development process, fostering innovation and the sharing of ideas.

Conclusion

Efthimios Koutris is a dedicated inventor whose work in ophthalmic pharmaceuticals holds promise for improving treatment options for patients with ocular conditions. His innovative formulations reflect a commitment to advancing healthcare solutions.